EP ELEDON PHARMACEUTICALS
Live / Allowed — Notice of allowance issued (as of 23 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99142210
- Mark type
- Word mark
- Filed
- 17 Apr 2025
- Published for opposition
- 28 Oct 2025
- Attorney of record
- Gregory B. Phillips
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation
Owner
- Eledon Pharmaceuticals, Inc., Irvine, CA, US
- Eledon Pharmaceuticals, Inc., Irvine, CA, US
Prosecution history
- 23 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
- 29 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
- 29 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
- 11 Sept 2025 — ASSIGNED TO EXAMINER
- 26 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Apr 2025 — NEW APPLICATION ENTERED